Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is the peritoneal membrane durable indefinitely?

M D Hallett1, B Charlton, P C Farrell

  • 1University of New South Wales, Sydney, Australia.

Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2017
Same author

Characterization of Seven Outbreaks of Hemorrhagic Hepatopathy Syndrome in Commercial Pullets Following the Administration of a Salmonella Enteritidis Bacterin in California.

Avian diseases·2016
Same author

Spatial and temporal epidemiology of infectious laryngotracheitis in central California: 2000-2012.

Avian diseases·2015
Same author

Retrospective study of turkey viral hepatitis in California turkey flocks, 2000-2012.

Avian diseases·2014
Same author

Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.

The European respiratory journal·2011
Same author

The isolation of exotic Newcastle disease (END) virus from nonpoultry avian species associated with the epidemic of END in chickens in southern California: 2002-2003.

Avian diseases·2005
Same journal

Treatment of a Dialysate Leak by Simultaneous Catheter Removal and Replacement in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

A Rare Complication During Percutaneous Peritoneal Dialysis Catheter Insertion: Intravesical Placement.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Is It Safe to Initiate Peritoneal Dialysis Treatment Immediately After Percutaneous Catheter Placement?

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Better Healing of the Exit Site with Negative-Pressure Wound Therapy.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

When Love Hurts, It Leaves No Options! An Unusual Case of Pasteurella Peritoneal Dialysis Peritonitis Causing Severe Intra-abdominal Adhesions Preventing a Future Peritoneal Dialysis Option.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
Same journal

Neisseria mucosa Peritonitis in the Setting of a Migrated Intrauterine Device.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018
See all related articles

Peritoneal membrane permeability is generally stable in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Monitoring residual renal function (RRF) and membrane performance is crucial for long-term CAPD success.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Peritoneal Dialysis

Background:

  • Peritoneal membrane permeability is typically maintained over time in continuous ambulatory peritoneal dialysis (CAPD).
  • Some evidence suggests a trend towards hyperpermeability in long-term CAPD patients, potentially causing ultrafiltration loss within 2-4 years.
  • Reduced peritonitis and catheter infections may prolong CAPD therapy, increasing focus on ultrafiltration loss and peritoneal membrane permeability.

Purpose of the Study:

  • To evaluate the long-term permeability characteristics of the peritoneal membrane in CAPD patients.
  • To investigate the role of residual renal function (RRF) decline in dialysis-related complications.
  • To emphasize the importance of routine monitoring of peritoneal membrane performance and RRF.

Main Methods:

Related Experiment Videos

  • Analysis of existing data on peritoneal membrane permeability and ultrafiltration capacity in CAPD patients.
  • Review of factors affecting technique survival, including peritonitis and infections.
  • Discussion on the significance of residual renal function (RRF) and its contribution to dialysis adequacy.

Main Results:

  • Peritoneal membrane permeability is generally well-maintained, with the membrane often outlasting the therapy's durability.
  • A subset of patients may experience hyperpermeability leading to ultrafiltration failure.
  • Decline in residual renal function (RRF) is identified as a critical factor in dialysis-related sequelae.

Conclusions:

  • Routine monitoring of peritoneal membrane mass transfer coefficient and RRF is essential for personalized CAPD management.
  • Early detection of changes in membrane permeability can help prevent inadequate dialysis.
  • Focusing on RRF and solute clearance is vital for optimizing long-term CAPD outcomes and patient stability.